Daniel Robert Lefebvre, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Orbit | 17 | 2024 | 457 | 3.450 |
Why?
|
Dacryocystorhinostomy | 8 | 2023 | 78 | 2.010 |
Why?
|
Orbital Diseases | 6 | 2024 | 178 | 1.980 |
Why?
|
Orbital Neoplasms | 8 | 2023 | 223 | 1.750 |
Why?
|
Eye Infections, Parasitic | 3 | 2024 | 26 | 1.670 |
Why?
|
Nasolacrimal Duct | 6 | 2023 | 79 | 1.400 |
Why?
|
Eye Injuries, Penetrating | 3 | 2024 | 124 | 1.380 |
Why?
|
Lacrimal Duct Obstruction | 3 | 2021 | 53 | 1.160 |
Why?
|
Orbital Fractures | 5 | 2020 | 109 | 1.040 |
Why?
|
Eyelid Neoplasms | 3 | 2019 | 89 | 0.990 |
Why?
|
Exophthalmos | 5 | 2023 | 97 | 0.960 |
Why?
|
Dacryocystitis | 4 | 2023 | 68 | 0.960 |
Why?
|
Eyelids | 7 | 2024 | 278 | 0.950 |
Why?
|
Mite Infestations | 1 | 2024 | 10 | 0.940 |
Why?
|
Orbital Cellulitis | 4 | 2024 | 33 | 0.930 |
Why?
|
Graves Ophthalmopathy | 5 | 2017 | 133 | 0.880 |
Why?
|
Diplopia | 4 | 2018 | 215 | 0.810 |
Why?
|
Cellulitis | 1 | 2024 | 209 | 0.810 |
Why?
|
Eye Infections, Fungal | 3 | 2016 | 100 | 0.730 |
Why?
|
Eye Diseases | 3 | 2022 | 655 | 0.730 |
Why?
|
Mucormycosis | 3 | 2016 | 103 | 0.730 |
Why?
|
Eyelid Diseases | 2 | 2024 | 157 | 0.720 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2021 | 242 | 0.650 |
Why?
|
Myiasis | 1 | 2018 | 14 | 0.610 |
Why?
|
Eye | 1 | 2022 | 710 | 0.590 |
Why?
|
Diptera | 1 | 2018 | 50 | 0.590 |
Why?
|
Hemangioma, Cavernous | 1 | 2018 | 107 | 0.590 |
Why?
|
Mucorales | 2 | 2016 | 35 | 0.560 |
Why?
|
Endoscopy | 10 | 2023 | 1851 | 0.560 |
Why?
|
Cosmetic Techniques | 1 | 2018 | 149 | 0.540 |
Why?
|
Ophthalmologic Surgical Procedures | 6 | 2024 | 356 | 0.520 |
Why?
|
Debridement | 3 | 2016 | 493 | 0.510 |
Why?
|
Hyaluronic Acid | 1 | 2018 | 482 | 0.480 |
Why?
|
Neurothekeoma | 1 | 2014 | 4 | 0.480 |
Why?
|
Orbital Pseudotumor | 1 | 2014 | 42 | 0.470 |
Why?
|
Acrospiroma | 1 | 2014 | 11 | 0.460 |
Why?
|
Immunocompromised Host | 2 | 2016 | 856 | 0.460 |
Why?
|
Apocrine Glands | 1 | 2014 | 32 | 0.460 |
Why?
|
Sphenoid Bone | 1 | 2015 | 177 | 0.450 |
Why?
|
Decompression, Surgical | 5 | 2017 | 608 | 0.450 |
Why?
|
Eccrine Glands | 1 | 2014 | 52 | 0.450 |
Why?
|
Alendronate | 1 | 2014 | 175 | 0.430 |
Why?
|
Eye Infections, Bacterial | 4 | 2016 | 242 | 0.410 |
Why?
|
Sweat Gland Neoplasms | 1 | 2014 | 116 | 0.400 |
Why?
|
Bone Resorption | 1 | 2015 | 723 | 0.380 |
Why?
|
Orbital Implants | 3 | 2021 | 22 | 0.370 |
Why?
|
Oculomotor Muscles | 3 | 2024 | 407 | 0.360 |
Why?
|
Conjunctiva | 1 | 2014 | 479 | 0.360 |
Why?
|
Collagen | 1 | 2018 | 2638 | 0.350 |
Why?
|
Sarcoma | 1 | 2021 | 1793 | 0.340 |
Why?
|
Diphosphonates | 1 | 2014 | 636 | 0.330 |
Why?
|
Biopsy | 6 | 2024 | 6768 | 0.310 |
Why?
|
Imidazoles | 1 | 2014 | 1179 | 0.310 |
Why?
|
Gloves, Surgical | 1 | 2007 | 24 | 0.300 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1066 | 0.290 |
Why?
|
Needlestick Injuries | 1 | 2007 | 71 | 0.290 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1405 | 0.280 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 795 | 0.280 |
Why?
|
Disease Management | 1 | 2016 | 2504 | 0.250 |
Why?
|
Diagnosis, Differential | 7 | 2024 | 12972 | 0.250 |
Why?
|
Inflammation | 2 | 2022 | 10760 | 0.240 |
Why?
|
Mites | 1 | 2024 | 46 | 0.240 |
Why?
|
Enophthalmos | 1 | 2024 | 34 | 0.240 |
Why?
|
Nasal Mucosa | 2 | 2018 | 415 | 0.230 |
Why?
|
Immunoenzyme Techniques | 1 | 2007 | 1704 | 0.230 |
Why?
|
Paranasal Sinuses | 2 | 2017 | 265 | 0.230 |
Why?
|
Remission, Spontaneous | 2 | 2015 | 384 | 0.230 |
Why?
|
Needles | 1 | 2007 | 451 | 0.230 |
Why?
|
Suture Techniques | 2 | 2014 | 771 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 10 | 2019 | 20555 | 0.220 |
Why?
|
Glomus Tumor | 1 | 2023 | 62 | 0.210 |
Why?
|
Photography | 2 | 2016 | 532 | 0.210 |
Why?
|
Blepharoplasty | 1 | 2023 | 61 | 0.210 |
Why?
|
Granuloma, Foreign-Body | 1 | 2022 | 42 | 0.200 |
Why?
|
Humans | 54 | 2024 | 761326 | 0.200 |
Why?
|
Transillumination | 1 | 2021 | 20 | 0.190 |
Why?
|
Silicones | 1 | 2022 | 227 | 0.190 |
Why?
|
Meningitis, Cryptococcal | 1 | 2022 | 67 | 0.190 |
Why?
|
Anophthalmos | 1 | 2021 | 23 | 0.190 |
Why?
|
Entropion | 1 | 2020 | 9 | 0.190 |
Why?
|
Retrospective Studies | 20 | 2023 | 80575 | 0.190 |
Why?
|
Operating Rooms | 1 | 2007 | 790 | 0.180 |
Why?
|
Middle Aged | 28 | 2023 | 220774 | 0.180 |
Why?
|
Ectropion | 1 | 2020 | 27 | 0.180 |
Why?
|
Male | 31 | 2024 | 360621 | 0.180 |
Why?
|
Surgical Flaps | 3 | 2018 | 1671 | 0.180 |
Why?
|
Muir-Torre Syndrome | 1 | 2019 | 12 | 0.170 |
Why?
|
Meibomian Glands | 1 | 2019 | 73 | 0.170 |
Why?
|
Maxillary Fractures | 1 | 2019 | 21 | 0.160 |
Why?
|
Zygomatic Fractures | 1 | 2019 | 35 | 0.160 |
Why?
|
Papilloma | 1 | 2019 | 141 | 0.160 |
Why?
|
Injections, Intraocular | 1 | 2018 | 33 | 0.160 |
Why?
|
Hypesthesia | 1 | 2019 | 107 | 0.150 |
Why?
|
Frontal Bone | 1 | 2018 | 105 | 0.150 |
Why?
|
Glucocorticoids | 2 | 2018 | 2163 | 0.150 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 282 | 0.140 |
Why?
|
Nematode Infections | 1 | 2017 | 19 | 0.140 |
Why?
|
Antifungal Agents | 3 | 2016 | 752 | 0.140 |
Why?
|
Transplantation, Heterotopic | 2 | 2007 | 174 | 0.140 |
Why?
|
Orbit Evisceration | 1 | 2016 | 9 | 0.140 |
Why?
|
Biometric Identification | 1 | 2016 | 5 | 0.140 |
Why?
|
Conjunctival Diseases | 1 | 2017 | 110 | 0.130 |
Why?
|
Female | 29 | 2024 | 392485 | 0.130 |
Why?
|
Vision Disorders | 2 | 2022 | 1088 | 0.130 |
Why?
|
Paranasal Sinus Diseases | 1 | 2016 | 121 | 0.130 |
Why?
|
Blinking | 1 | 2016 | 133 | 0.130 |
Why?
|
Syndrome | 1 | 2022 | 3268 | 0.130 |
Why?
|
Adult | 20 | 2024 | 221122 | 0.130 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2015 | 87 | 0.120 |
Why?
|
Ophthalmic Artery | 1 | 2015 | 58 | 0.120 |
Why?
|
Aged | 20 | 2023 | 169179 | 0.120 |
Why?
|
Face | 2 | 2023 | 1026 | 0.120 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5820 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 6 | 2024 | 36430 | 0.120 |
Why?
|
Eye Enucleation | 3 | 2021 | 128 | 0.120 |
Why?
|
Immunohistochemistry | 2 | 2021 | 11070 | 0.120 |
Why?
|
Skull Fractures | 1 | 2015 | 202 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 422 | 0.110 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2016 | 251 | 0.110 |
Why?
|
Panophthalmitis | 1 | 2013 | 6 | 0.110 |
Why?
|
Prostaglandins, Synthetic | 1 | 2013 | 24 | 0.110 |
Why?
|
Aspergillosis | 1 | 2015 | 243 | 0.110 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2015 | 119 | 0.110 |
Why?
|
Ocular Motility Disorders | 1 | 2014 | 144 | 0.110 |
Why?
|
Skin Abnormalities | 1 | 2013 | 59 | 0.100 |
Why?
|
Pseudomonas Infections | 1 | 2016 | 623 | 0.100 |
Why?
|
Cysts | 1 | 2017 | 681 | 0.100 |
Why?
|
Eye Evisceration | 2 | 2021 | 22 | 0.090 |
Why?
|
Hemangioma | 1 | 2016 | 727 | 0.090 |
Why?
|
Morbidity | 1 | 2016 | 1750 | 0.090 |
Why?
|
Mycoses | 1 | 2014 | 386 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1640 | 0.090 |
Why?
|
Light | 1 | 2016 | 1351 | 0.090 |
Why?
|
Accidents, Traffic | 1 | 2015 | 816 | 0.080 |
Why?
|
Visual Acuity | 1 | 2019 | 2671 | 0.080 |
Why?
|
Blindness | 1 | 2013 | 584 | 0.080 |
Why?
|
Escherichia coli Infections | 1 | 2013 | 523 | 0.080 |
Why?
|
Postoperative Care | 1 | 2015 | 1471 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1420 | 0.080 |
Why?
|
Pseudomonas aeruginosa | 1 | 2016 | 1279 | 0.080 |
Why?
|
Cornea | 1 | 2016 | 1332 | 0.080 |
Why?
|
Antigens, CD | 1 | 2018 | 4000 | 0.080 |
Why?
|
Horseradish Peroxidase | 1 | 2007 | 166 | 0.070 |
Why?
|
Reference Values | 1 | 2015 | 4921 | 0.070 |
Why?
|
Femoral Vein | 1 | 2007 | 153 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2023 | 58946 | 0.070 |
Why?
|
Equipment Contamination | 1 | 2007 | 181 | 0.070 |
Why?
|
Sinusitis | 1 | 2015 | 991 | 0.070 |
Why?
|
Accidents, Occupational | 1 | 2007 | 249 | 0.060 |
Why?
|
Femoral Artery | 2 | 2007 | 827 | 0.060 |
Why?
|
Software | 2 | 2016 | 4439 | 0.060 |
Why?
|
Treatment Outcome | 8 | 2023 | 64645 | 0.060 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2007 | 250 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3800 | 0.050 |
Why?
|
Glaucoma | 1 | 2013 | 1185 | 0.050 |
Why?
|
Heart Transplantation | 2 | 2007 | 3234 | 0.050 |
Why?
|
Recurrence | 1 | 2015 | 8470 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2015 | 3413 | 0.050 |
Why?
|
Young Adult | 4 | 2019 | 59196 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39108 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2328 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3611 | 0.050 |
Why?
|
Cadaver | 2 | 2016 | 1358 | 0.050 |
Why?
|
Adolescent | 3 | 2018 | 88305 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8997 | 0.040 |
Why?
|
Oculomotor Nerve | 1 | 2019 | 72 | 0.040 |
Why?
|
Quality of Life | 2 | 2017 | 13355 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1703 | 0.040 |
Why?
|
Edema | 1 | 2022 | 770 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12144 | 0.040 |
Why?
|
Animals | 5 | 2018 | 168388 | 0.040 |
Why?
|
Rats, Inbred ACI | 2 | 2007 | 34 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 30044 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2021 | 592 | 0.030 |
Why?
|
Postoperative Complications | 4 | 2023 | 15647 | 0.030 |
Why?
|
Hospitals, Special | 1 | 2016 | 92 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1272 | 0.030 |
Why?
|
Nasal Septum | 1 | 2016 | 130 | 0.030 |
Why?
|
Aspergillus | 1 | 2015 | 93 | 0.030 |
Why?
|
Rats, Inbred Lew | 2 | 2007 | 1158 | 0.030 |
Why?
|
Tenotomy | 1 | 2014 | 55 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 165 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2007 | 3847 | 0.030 |
Why?
|
Nasal Cavity | 1 | 2016 | 304 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2052 | 0.030 |
Why?
|
Cloprostenol | 1 | 2013 | 21 | 0.030 |
Why?
|
Baseball | 1 | 2014 | 95 | 0.030 |
Why?
|
Prostaglandins F, Synthetic | 1 | 2013 | 32 | 0.030 |
Why?
|
Endoscopes | 1 | 2013 | 168 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1813 | 0.030 |
Why?
|
Maxillary Sinus | 1 | 2013 | 180 | 0.020 |
Why?
|
Ophthalmoplegia | 1 | 2013 | 168 | 0.020 |
Why?
|
Blepharoptosis | 1 | 2013 | 144 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20092 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36202 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7439 | 0.020 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 539 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1858 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2024 | 4063 | 0.020 |
Why?
|
Amides | 1 | 2013 | 449 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2013 | 393 | 0.020 |
Why?
|
Ophthalmology | 1 | 2016 | 550 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2016 | 1985 | 0.020 |
Why?
|
Osteotomy | 1 | 2015 | 837 | 0.020 |
Why?
|
Otolaryngology | 1 | 2016 | 693 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4302 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 54405 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4908 | 0.020 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2007 | 69 | 0.020 |
Why?
|
Pulse | 1 | 2007 | 219 | 0.020 |
Why?
|
Palpation | 1 | 2007 | 166 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5077 | 0.020 |
Why?
|
Ultrasonography | 1 | 2019 | 5970 | 0.020 |
Why?
|
Carotid Artery, Common | 1 | 2007 | 175 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21009 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8632 | 0.020 |
Why?
|
Bacteria | 1 | 2016 | 2216 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8526 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2007 | 983 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8837 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12710 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18401 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6478 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15835 | 0.010 |
Why?
|
Rats | 2 | 2007 | 23729 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12059 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29588 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1938 | 0.010 |
Why?
|
Child | 2 | 2016 | 80156 | 0.010 |
Why?
|
Acute Disease | 1 | 2007 | 7238 | 0.010 |
Why?
|
Heart Rate | 1 | 2007 | 4197 | 0.010 |
Why?
|
Echocardiography | 1 | 2007 | 4991 | 0.010 |
Why?
|
Myocardium | 1 | 2007 | 4723 | 0.010 |
Why?
|
Graft Rejection | 1 | 2007 | 4446 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26108 | 0.010 |
Why?
|
United States | 1 | 2019 | 72317 | 0.010 |
Why?
|
Risk Factors | 1 | 2015 | 74152 | 0.000 |
Why?
|